当前位置： SCI文献检索 > Clinical and Experimental Nephrology期刊下所有文献 > Relationship of late arteriovenous fistula stenosis with soluble E-selectin and soluble EPCR in chronic hemodialysis patients with arteriovenous fistula.

Relationship of late arteriovenous fistula stenosis with soluble E-selectin and soluble EPCR in chronic hemodialysis patients with arteriovenous fistula.

Abstract：

BACKGROUND/AIMS:Vascular access dysfunction caused by stenosis is a major complication for hemodialysis (HD) patients. However, physiopathology of late arteriovenous fistula (AVF) stenosis is still under investigation. The aim of the present study was to evaluate the association between plasma soluble EPCR (sEPCR) with serum soluble E-selectin (sE-selectin) concentration and late AVF stenosis in HD patients. METHODS:Plasma sEPCR and serum sE-selectin concentrations were measured in 94 HD patients. Using these data, we studied the association of sEPCR and sE-selectin with the presence and degree of AVF stenosis using ultrasonography and fistulogram. RESULTS:Fifty-one patients have AVF stenosis, and the others (n = 43) have patent AVF. The degree of AVF stenosis was correlated with serum sE-selectin levels (r = 0.351, p = 0.01), but not sEPCR (r = 0.075, p = 0.702). The median level of sE-selectin was statistically higher in the group of AVF stenosis than in the group of patent AVF [463.2 pg/ml (275.4-671.4) vs. 162.5 pg/ml (96.7-285.3), p = 0.001]. Increased sE-selectin levels [OR (OR) = 6.356, p = 0.015] and high levels of LDL (OR = 4.321, p = 0.044) were independent predictors of late AVF stenosis in the multivariate model. CONCLUSIONS:sE-selectin and the LDL were the most important predictors of late AVF stenosis. In addition, sE-selectin correlated with the degree of AVF stenosis. We suggested that atherosclerosis might be contributing factor for development of late AVF stenosis.

journal_name

Clin Exp Nephrol

journal_title

Clinical and experimental nephrology

authors

Bilgic MA,Yilmaz H,Bozkurt A,Celik HT,Bilgic IC,Gurel OM,Kirbas I,Bavbek N,Akcay A

doi

10.1007/s10157-014-0955-4

subject

Has Abstract

pub_date

2015-02-01 00:00:00

pages

133-9

issue

1

eissn

1342-1751

issn

1437-7799

journal_volume

19

pub_type

杂志文章

相关文献

Clinical and Experimental Nephrology文献大全
  • Nephronophthisis in two siblings.

    abstract：:We describe here two sisters with nephronophthisis, which was not detected until the development of endstage renal failure. Twenty- and 15-year-old female siblings were admitted to our hospital for further examination of renal dysfunction. No urinalysis abnormalities had been found in yearly health checks in either pa...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-005-0377-4

    authors： Ashizawa M,Miyazaki M,Furusu A,Abe K,Kanamoto Y,Iwanaga N,Ozono Y,Harada T,Taguchi T,Kohno S

    更新日期：2005-12-01 00:00:00

  • Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients.

    abstract：BACKGROUND:Autosomal dominant polycystic kidney disease (ADPKD), one of the most common hereditary kidney diseases, causes gradual growth of cysts in the kidneys, leading to renal failure. Owing to the advanced technology of next-generation sequencing (NGS), genetic analyses of the causative genes PKD1 and PKD2 have be...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-019-01736-3

    authors： Mochizuki T,Teraoka A,Akagawa H,Makabe S,Akihisa T,Sato M,Kataoka H,Mitobe M,Furukawa T,Tsuchiya K,Nitta K

    更新日期：2019-08-01 00:00:00

  • Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease.

    abstract：BACKGROUND:Tolvaptan slowed the rates of total kidney volume (TKV) growth and renal function decline over a 3-year period in patients with autosomal dominant polycystic kidney disease (ADPKD) enrolled in the Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes (TE...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-020-02009-0

    authors： Horie S,Muto S,Kawano H,Okada T,Shibasaki Y,Nakajima K,Ibuki T

    更新日期：2021-01-20 00:00:00

  • Granulomatous transformation of capillary lesions in pulmonary-renal syndrome autologously induced anti-glomerular basement membrane disease in Wistar-Kyoto rats.

    abstract：BACKGROUND:Pulmonary-renal syndrome is characterized by pulmonary hemorrhage and rapidly progressive glomerulonephritis in various immunological states. Histopathological analysis of pulmonary-renal syndrome is not yet complete. METHODS:Wistar-Kyoto (WKY) rats were sensitized using the noncollagenous (NC1) domain of t...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-009-0260-9

    authors： Aoyagi D,Nakazawa K,Kaneyama T,Masumoto J,Otani M,Shigematsu H

    更新日期：2010-04-01 00:00:00

  • Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.

    abstract：:Waldenström's macroglobulinemia is rare lymphoproliferative disorder characterized by the presence of a monoclonal IgM paraproteinemia. Cryoglobulinemia is a common sequela of Waldenström's macroglobulinemia present in 8-18% of the patients. Cryoglobulinemia has also been described as occurring after treatment with ri...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-008-0042-9

    authors： Shaikh A,Habermann TM,Fidler ME,Kumar S,Leung N

    更新日期：2008-08-01 00:00:00

  • Tubulointerstitial nephritis without glomerular lesions in three patients with myeloperoxidase-ANCA-associated vasculitis.

    abstract：BACKGROUND:Myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis frequently induces crescentic glomerulonephritis. However, a few cases have so far been reported to have only tubulointerstitial (TI) nephritis without any apparent glomerular lesions. We recently treated three similar cases...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-009-0200-8

    authors： Nakabayashi K,Sumiishi A,Sano K,Fujioka Y,Yamada A,Karube M,Koji H,Arimura Y,Nagasawa T

    更新日期：2009-12-01 00:00:00

  • Factors affecting the progression of renal dysfunction and the importance of salt restriction in patients with type 2 diabetic kidney disease.

    abstract：BACKGROUND:Type 2 diabetic kidney disease (DKD) is the most common cause of end-stage renal failure, and the prevention of its progression has been a topic of discussion. METHODS:Sixty type 2 DKD patients were retrospectively evaluated for 1 year. Factors independently affecting the annual Ccr decline were examined by...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-015-1118-y

    authors： Kanauchi N,Ookawara S,Ito K,Mogi S,Yoshida I,Kakei M,Ishikawa SE,Morishita Y,Tabei K

    更新日期：2015-12-01 00:00:00

  • Adult onset Fanconi syndrome: extensive tubulo-interstitial lesions and glomerulopathy in the early stage of Chinese herbs nephropathy.

    abstract：:A 33-year-old woman was transferred to our hospital with a 5-month history of taking Chinese herbal medicine containing aristolochic acid. She presented with metabolic acidosis, severe anemia, hypophosphatemia and uric aciduria, and generalized aminoaciduria and glycosuria, features which were consistent with the clin...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-004-0296-9

    authors： Kazama I,Matsubara M,Michimata M,Suzuki M,Hatano R,Sato H,Ito S

    更新日期：2004-09-01 00:00:00

  • NF-kappaB-dependent genes induced by proteinuria and identified using DNA microarrays.

    abstract：BACKGROUND:A close correlation has been shown between tubulointerstitial (TI) injury and the outcome of renal dysfunction, and nuclear factor-kappaB (NFkappaB) has been shown to play a key role in proteinuria-induced TI injury. To explore the molecular mechanisms of the proteinuria-induced TI injury further, we have an...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-008-0038-5

    authors： Takase O,Marumo T,Hishikawa K,Fujita T,Quigg RJ,Hayashi M

    更新日期：2008-06-01 00:00:00

  • Current status and issues of C1q nephropathy.

    abstract：:C1q nephropathy, first proposed by Jennette and Hipp [Am J Clin Pathol 83:415-420, 1985; Am J Kidney Dis 6:103-110, 1985], was described as a distinct glomerular disease entity characterized by extensive mesangial deposition of C1q, with associated mesangial immune complexes, and the absence of any clinical and labora...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章,评审

    doi：10.1007/s10157-009-0159-5

    authors： Mii A,Shimizu A,Masuda Y,Fujita E,Aki K,Ishizaki M,Sato S,Griesemer A,Fukuda Y

    更新日期：2009-08-01 00:00:00

  • CD16+CD56+ cells are a potential culprit for hematuria in IgA nephropathy.

    abstract：BACKGROUND:Hematuria is the first manifestation of urinary abnormality in immunoglobulin A nephropathy (IgAN). Hematuria has recently been reported as a risk factor for deterioration of renal function; however, its cause remains unknown. METHODS:We analyzed the surface marker of peripheral blood mononuclear cells befo...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-014-0968-z

    authors： Iwatani H,Nagasawa Y,Yamamoto R,Iio K,Mizui M,Horii A,Kitahara T,Inohara H,Kumanogoh A,Imai E,Rakugi H,Isaka Y

    更新日期：2015-04-01 00:00:00

  • Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling.

    abstract：BACKGROUND:Adenosine monophosphate (AMP)-activated protein kinase (AMPK), as a sensor of cellular energy status, has been known to play an important role in the pathophysiology of diabetes and its complications. As AMPK is also expressed in podocytes, it is possible that podocyte AMPK would be an important contributing...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-012-0649-8

    authors： Choi JY,Ha TS,Park HY,Ahn HY

    更新日期：2013-02-01 00:00:00

  • Relationship between antinuclear antibody and microalbuminuria in the general population: the Takahata study.

    abstract：BACKGROUND:Microalbuminuria, a marker of vascular damage, is associated with increased risk of progressive renal deterioration, cardiovascular disease and mortality. However, the relationship between antinuclear antibody (ANA) and microalbuminuria in the general population is unknown. Thus, we conducted a cross-section...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-008-0030-0

    authors： Ishikawa M,Konta T,Hao Z,Takasaki S,Abiko H,Takahashi T,Ikeda A,Ichikawa K,Shibata Y,Takeishi Y,Kato T,Kawata S,Kubota I

    更新日期：2008-06-01 00:00:00

  • Upregulation of prolactin receptor in proximal tubular cells was induced in cardiac dysfunction model mice.

    abstract：BACKGROUND:In order to clarify the interaction between cardiac dysfunction and sodium homeostasis in the kidney, we used a murine model of cardiac dysfunction and investigated the effect on sodium transporters in renal tubular cells. METHODS:Cardiac function was deteriorated by abdominal aortic banding, and the gene e...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-013-0820-x

    authors： Tsuchida Y,Kaneko Y,Otsuka T,Goto K,Saito A,Yamamoto K,Yamamoto T,Narita I

    更新日期：2014-02-01 00:00:00

  • Clinical outcomes after percutaneous coronary intervention in non-dialysis patients with acute coronary syndrome and advanced renal dysfunction.

    abstract：BACKGROUND:Data about the clinical outcomes of ACS patients with advanced renal dysfunction (estimated glomerular filtration rate < 30 mL/min/1.73 m2) following percutaneous coronary intervention (PCI) are limited. METHODS:We examined the data obtained from 194 ACS patients with non-dialysis advanced renal dysfunction...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s10157-019-01839-x

    authors： Uemura Y,Ishikawa S,Takemoto K,Negishi Y,Tanaka A,Takagi K,Yoshioka N,Umemoto N,Inoue Y,Morishima I,Shibata N,Asano H,Ishii H,Watarai M,Murohara T,N-registry investigators.

    更新日期：2020-04-01 00:00:00

  • A clinical pharmacology study of the novel, selective urate reabsorption inhibitor dotinurad in outpatients.

    abstract：BACKGROUND:Dotinurad is a novel, selective urate reabsorption inhibitor (SURI), which reduces serum uric acid levels by selective inhibition of the urate transporter 1 (URAT1). The Japanese guideline for the management of hyperuricemia and gout recommends that drug selection should be based on classification of hyperur...

    journal_title：Clinical and experimental nephrology

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1007/s10157-020-01857-0

    authors： Hosoya T,Furuno K,Kanda S

    更新日期：2020-03-01 00:00:00

  • Effect of glomerular filtration rate and proteinuria on medical cost among screened subjects.

    abstract：BACKGROUND:Chronic kidney disease is a predictor of end-stage renal disease (ESRD) and cardiovascular disease (CVD). Therefore, the medical expenses are higher with the decrease in glomerular filtration rate (GFR). However, few studies have examined the medical expenses according to the baseline GFR. METHODS:We invest...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-012-0718-z

    authors： Iseki K,Iseki C,Kurahashi I,Watanabe T

    更新日期：2013-06-01 00:00:00

  • Clinical pharmacological study of dotinurad administered to male and female elderly or young subjects.

    abstract：BACKGROUND:Dotinurad is a novel selective urate reabsorption inhibitor (SURI) that selectively inhibits the reabsorption of uric acid in renal tubules and promotes the excretion of uric acid into urine. In this study, the effects of age and gender on the pharmacokinetics (PK), pharmacodynamics (PD), and safety of dotin...

    journal_title：Clinical and experimental nephrology

    pub_type： 临床试验,杂志文章

    doi：10.1007/s10157-019-01836-0

    authors： Nakatani H,Fushimi M,Sasaki T,Okui D,Ohashi T

    更新日期：2020-03-01 00:00:00

  • Anion gap predicts early mortality after starting hemodialysis in the elderly.

    abstract：BACKGROUND:Serum anion gap (AG) has recently been proven to represent a biomarker for predicting prognosis in patients with end-stage renal disease (ESRD). However, whether change in AG (ΔAG) at the time of starting hemodialysis predicts mortality after starting hemodialysis in elderly patients with ESRD remains unknow...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-019-01844-0

    authors： Arai Y,Tanaka H,Shioji S,Sakamoto E,Kondo I,Suzuki M,Katagiri D,Tada M,Hinoshita F

    更新日期：2020-05-01 00:00:00

  • Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study.

    abstract：BACKGROUND:Dotinurad, a novel selective urate reabsorption inhibitor (SURI), reduces serum uric acid levels by selectively inhibiting urate transporter 1 (URAT1) for the treatment of hyperuricemia with or without gout. We confirmed the serum uric acid lowering effect and safety of dotinurad. METHODS:This was a confirm...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1007/s10157-019-01818-2

    authors： Hosoya T,Sano T,Sasaki T,Fushimi M,Ohashi T

    更新日期：2020-03-01 00:00:00

  • Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD).

    abstract：BACKGROUND:The number of patients with chronic kidney disease (CKD) in Japan is currently rising. Therefore, measures to control the progression of CKD from a predialysis condition to endstage renal failure are urgently required. We are conducting a clinical trial to investigate the efficacy of an oral carbonaceous ads...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-005-0358-7

    authors： Morita S,Fukuhara S,Akizawa T,Asano Y,Kurokawa K

    更新日期：2005-09-01 00:00:00

  • Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury.

    abstract：:Recently, there has been a paradigm shift away from an emphasis on the role of the endocrine (circulating) renin-angiotensin system (RAS) in the regulation of the sodium and extracellular fluid balance, blood pressure, and the pathophysiology of hypertensive organ damage toward a focus on the role of tissue RAS found ...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章,评审

    doi：10.1007/s10157-011-0568-0

    authors： Kagami S

    更新日期：2012-04-01 00:00:00

  • Cardiorenal connection in chronic kidney disease.

    abstract：:Chronic kidney disease (CKD), as defined by reduced glomerular filtration rate (<60 ml/min/1.73 m(2)) and/or the presence of renal damage for >3 months, is a significant threat for public health in modern societies. Recent epidemiological studies have demonstrated that CKD is a significant risk for cardiovascular even...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章,评审

    doi：10.1007/s10157-011-0493-2

    authors： Ito S

    更新日期：2012-02-01 00:00:00

  • Pathology of glomerular lipidosis.

    abstract：:Glomerular lipid deposition is sometimes associated with a particular kind of lipid metabolism disturbance. Ultrastructural analyses using electron microscopy often indicate a disease-specific aspect of intraglomerular lipid distribution. ...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章,评审

    doi：10.1007/s10157-013-0882-9

    authors： Sato H,Takahashi N,Sato E,Kisu K,Ito S,Saito T

    更新日期：2014-04-01 00:00:00

  • Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.

    abstract：BACKGROUND/AIMS:Fibroblast growth factor 23 (FGF23) and soluble α-Klotho are emerging potential biomarkers of phosphorus and vitamin D metabolism which change in concentration in early chronic kidney disease (CKD) in order to maintain normal phosphorus levels. Tubular reabsorption of phosphate (TRP) has been commonly u...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-014-0962-5

    authors： Hong YA,Lim JH,Kim MY,Kim Y,Yang KS,Chung BH,Chung S,Choi BS,Yang CW,Kim YS,Chang YS,Park CW

    更新日期：2015-04-01 00:00:00

  • Cost-effectiveness of chronic kidney disease mass screening test in Japan.

    abstract：BACKGROUND:Chronic kidney disease (CKD) is a significant public health problem. Strategy for its early detection is still controversial. This study aims to assess the cost-effectiveness of population strategy, i.e. mass screening, and Japan's health checkup reform. METHODS:Cost-effectiveness analysis was carried out t...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-011-0567-1

    authors： Kondo M,Yamagata K,Hoshi SL,Saito C,Asahi K,Moriyama T,Tsuruya K,Yoshida H,Iseki K,Watanabe T

    更新日期：2012-04-01 00:00:00

  • Tubulointerstitial nephritis and uveitis syndrome associated with hyperthyroidism.

    abstract：:We report a 17-year-old male patient with tubulointerstitial nephritis and uveitis (TINU) associated with hyperthyroidism. He presented with a 2-month history of fatigue, loss of appetite, low-grade fever, and a 12-kg weight loss when he was admitted to our hospital. He had iritis, which was complicated by fibrin in t...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-006-0423-x

    authors： Ebihara I,Hirayama K,Usui J,Seki M,Higuchi F,Oteki T,Kobayashi M,Yamagata K

    更新日期：2006-09-01 00:00:00

  • Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study.

    abstract：BACKGROUND:Hyperuricemia is an established risk factor for cardiovascular events and mortality. This study investigated the association between serum uric acid and the incidence of nonfatal stroke in a Japanese community-based population. METHODS:We used a nationwide database of 155,322 subjects (aged 40-73, male 39 %...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-016-1311-7

    authors： Kamei K,Konta T,Hirayama A,Ichikawa K,Kubota I,Fujimoto S,Iseki K,Moriyama T,Yamagata K,Tsuruya K,Narita I,Kondo M,Shibagaki Y,Kasahara M,Asahi K,Watanabe T

    更新日期：2017-06-01 00:00:00

  • Biological variation of procalcitonin levels in hemodialysis patients.

    abstract：BACKGROUND:There is no obvious evidence regarding biological variation of procalcitonin (PCT) levels in hemodialysis (HD) patients without infections. The aim of this study was to determine the within- and between-person biological variation of PCT levels in HD patients without infections. METHODS:A multicenter, prosp...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s10157-018-1639-2

    authors： Kubo S,Iwasaki M,Horie M,Matsukane A,Hayashi T,Tanaka Y,Hase H,Joki N

    更新日期：2019-03-01 00:00:00

  • The choice of comorbidity scoring system in Chinese peritoneal dialysis patients.

    abstract：BACKGROUND:Several comorbidity scoring systems have been developed and validated, mostly in western hemodialysis patients with a high risk of cardiovascular disease. The performance of comorbidity scoring, however, depends on the patient population. In this study, we determine the optimal comorbidity scoring system for...

    journal_title：Clinical and experimental nephrology

    pub_type： 杂志文章

    doi：10.1007/s10157-017-1418-5

    authors： Ma TK,Chow KM,Kwan BC,Ng JK,Pang WF,Leung CB,Li PK,Szeto CC

    更新日期：2018-02-01 00:00:00